Begin your TipRanks Premium journey today. Longboard Pharmaceuticals (LBPH) Company Description: Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel ...

On Monday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $59.5 which represents a decrease of $-0.19 or -0.32% from the prior close of $59.69. The stock opened at $59.66 ...

Longboard Pharmaceuticals, Inc. ( (LBPH) ) has released its Q3 earnings. Here is a breakdown of the information Longboard Pharmaceuticals, Inc.

In terms of valuation, Longboard Pharmaceuticals Inc’s market capitalization stands at $2.33 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a ...

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have earned an average rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat.com reports.

We are headquartered at the Empire State Building in New York City and are investigating Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), relating to a tender offer from H. Lundbeck A/S.

On Tuesday, Citi reaffirmed its Buy rating and $40.00 price target for Longboard Pharmaceuticals Inc (NASDAQ:LBPH). The endorsement follows Longboard's announcement of promising ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...